IncobotulinumtoxinA for the treatment of spasticity in children with cerebral palsy - a retrospective case series focusing on dosing and tolerability. [electronic resource]
- BMC neurology Apr 2020
- 126 p. digital
Publication Type: Journal Article
1471-2377
10.1186/s12883-020-01702-7 doi
Adolescent Botulinum Toxins, Type A--administration & dosage Cerebral Palsy--drug therapy Child Child, Preschool Female Humans Infant Male Muscle Spasticity--drug therapy Muscle Weakness--chemically induced Neuromuscular Agents--therapeutic use Retrospective Studies Treatment Outcome